Biodexa Pharmaceuticals (BDRX) Profit After Tax (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Profit After Tax of $0.0 for Q2 2025, down 79.21% sequentially from $0.0 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Profit After Tax (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 13 years of Profit After Tax data on file, last reported at $0.0 in Q2 2025.
- For the quarter ending Q2 2025, Profit After Tax changed N/A year-over-year to $0.0; the trailing twelve-month figure through Jun 2025 stood at -$14.1 million (changed N/A YoY), and the FY2025 full-year result was $3955.5, up 100.05% from the prior year.
- Profit After Tax eased to $0.0 in Q2 2025, from $0.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $0.0 in Q4 2024 to a low of -$10.4 million in Q4 2022.
- A 5-year average of -$5.2 million and a median of -$4.9 million in 2021 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 2897.84% in 2021 and soared 100.0% in 2024, its largest moves.
- Tracing BDRX's Profit After Tax over 5 years: stood at -$7.4 million in 2021, then slumped by 41.51% to -$10.4 million in 2022, then rose by 10.81% to -$9.3 million in 2023, then jumped by 100.0% to $0.0 in 2024, then slumped by 79.21% to $0.0 in 2025.
- Business Quant data shows BDRX's Profit After Tax at $0.0 in Q2 2025, $0.0 in Q4 2024, and -$9.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Dec 31, 2023 | -9.29 Mn |
| Jun 30, 2023 | -4.83 Mn |
| Dec 31, 2022 | -10.42 Mn |
| Sep 14, 2022 | -4.62 Mn |
| Dec 31, 2021 | -7.36 Mn |
| Sep 17, 2021 | -5.04 Mn |
| Dec 31, 2020 | -29.30 Mn |
| Sep 10, 2020 | 180,077.09 |
| Dec 31, 2019 | -11.75 Mn |
| Dec 31, 2018 | -13.34 Mn |
| Dec 31, 2017 | -15.54 Mn |
| Dec 31, 2016 | -12.56 Mn |
| Dec 31, 2015 | -30.60 Mn |
| Dec 31, 2014 | -13.98 Mn |
| Dec 31, 2013 | -7.91 Mn |